{
    "clinical_study": {
        "@rank": "161392", 
        "arm_group": {
            "arm_group_label": "Valiant Mona LSA Stent Graft System", 
            "arm_group_type": "Experimental", 
            "description": "TEVAR procedure using Medtronic Stent Graft"
        }, 
        "brief_summary": {
            "textblock": "The Valiant Mona LSA thoracic stent graft system is for the endovascular repair of aneurysms\n      of the descending thoracic aorta (DTA) in patients who require coverage of the left\n      subclavian artery (LSA).The study is intended to assess safety and performance of the device\n      acutely and at 30 days."
        }, 
        "brief_title": "Safety and Efficacy of Valiant Mona LSA Stent Graft System", 
        "completion_date": {
            "#text": "February 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Thoracic Aortic Aneurysms", 
        "condition_browse": {
            "mesh_term": [
                "Aneurysm", 
                "Aortic Aneurysm", 
                "Aortic Aneurysm, Thoracic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject is at least 18 years of age.\n\n          -  The subject or legal guardian understands the nature of the study and agrees to its\n             provisions on a written informed consent form\n\n          -  Subject must be considered a candidate for revascularization of the LSA.\n\n          -  Subject has a DTA which will require coverage of the LSA\n\n          -  Subject's anatomy must meet the anatomical criteria to receive that implanted device\n\n        Exclusion Criteria:\n\n          -  Subject has had previous endovascular repair of the ascending and/or descending\n             thoracic aorta.\n\n          -  Subject is in acute renal failure or has renal insufficiency with a serum creatinine\n             \u2265 2.0 mg/dL\n\n          -  Subject is a pregnant female.\n\n          -  Enrollment in another clinical study\n\n          -  Subject has had a cerebral vascular accident (CVA)or myocardial infarction (MI)\n             within 3 months.\n\n          -  Subject has a history of bleeding diathesis, coagulopathy, or refuses blood\n             transfusion.\n\n          -  Subject has a known allergy or intolerance to the device components.\n\n          -  Subject has a known hypersensitivity or contraindication to anticoagulants or\n             contrast media, which is not amenable to pre-treatment."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01839695", 
            "org_study_id": "10086370DOCRev1C"
        }, 
        "intervention": {
            "arm_group_label": "Valiant Mona LSA Stent Graft System", 
            "description": "All subjects will be implanted with this device", 
            "intervention_name": "Valiant Mona LSA Stent Graft System", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Thoracic Aneurysm", 
            "Endovascular Aortic Repair", 
            "TEVAR"
        ], 
        "lastchanged_date": "January 13, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28203"
                    }, 
                    "name": "Sanger Heart and Vascular Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "27465"
                    }, 
                    "name": "Cleveland Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom"
                    }, 
                    "name": "St George's Vascular Institute, St. George's Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "Valiant Mona LSA Stent Graft System Early Feasibility Study", 
        "overall_official": {
            "affiliation": "The Cleveland Clinic", 
            "last_name": "Eric Roselli, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Cumulative Major Adverse events (including aneurysm-related mortality, stroke, paraplegia, and left arm/hand ischemia)", 
            "measure": "Primary Safety Endpoint", 
            "safety_issue": "Yes", 
            "time_frame": "1 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01839695"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Endoleak of all types from the stent graft", 
            "measure": "Endoleak", 
            "safety_issue": "Yes", 
            "time_frame": "60 months"
        }, 
        "source": "Medtronic Endovascular", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medtronic Endovascular", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}